Modulation of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment

10Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Paracoccidioides brasiliensis, a thermo-dimorphic fungus, is the ethiologic agent of patacoccidioidomycosis (PCM). The recidive is the greatest obstacle of this disease, because the yeast usually returns after the long treatment period. In the present work, we have investigated the cellular immune response of cells from peripheral blood drawn from patients with different duration of PCM. The classification of patients ranged from nontreated to those with long-standing disease over 5 years. Unstimulated as well as cells stimulated with phytohemaglutinin or two different antigen preparations, secreted (MEXO) or somatic (PbAg) of P. brasiliensis, were characterized. We found that cells from patients with disease proliferate considerably upon stimulation with the antigen preparations and that cells from patients with disease of long duration does not proliferate that vigorously as from patients with more recent diagnosis. Both interferon (IFN)-γ and interleukin (IL)-4 appear to be increased in patients, but IFN-γ tended to increase upon treatment while IL-4-secretion decreased. With respect to CD28 and CD86, we found that the subset of CD28 positive CD8 cells are decreased in all stages of the disease as compared to control individuals. A subset of CD86 positive CD19 cells appeared to be considerably increased compared to the controls. Indeed, our results demonstrated that the treatment of PCM patients promoted a regulation of IFN-γ, IL-4 levels and CD28, CD86 expression bringing new insight to the cellular immune response in PCM.

References Powered by Scopus

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

232813Citations
N/AReaders
Get full text

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy

1654Citations
N/AReaders
Get full text

Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling

326Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Interleukin-10 and Tumor Necrosis Factor-α Single Nucleotide Gene Polymorphism Frequency in Paracoccidioidomycosis

29Citations
N/AReaders
Get full text

Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy

23Citations
N/AReaders
Get full text

Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: Lack of correlation with T-cell hyporesponsiveness

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bozzi, A., Reis, B. S., Prado, F. L. S., Pedroso, E. P., Leite, M. F., & Goes, A. M. (2004). Modulation of CD28 and CD86 expression in patients with paracoccidioidomycosis in different periods of treatment. Scandinavian Journal of Immunology, 60(5), 500–505. https://doi.org/10.1111/j.0300-9475.2004.01501.x

Readers' Seniority

Tooltip

Researcher 5

42%

Professor / Associate Prof. 4

33%

PhD / Post grad / Masters / Doc 3

25%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 6

46%

Medicine and Dentistry 3

23%

Immunology and Microbiology 3

23%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Save time finding and organizing research with Mendeley

Sign up for free